Mesa Laboratories MLAB
NASDAQ MLAB
$121.13 -2.78 (-2.24%)
As of: Sep 10, 2026 · 3:59 PM EDT

Mesa Laboratories (MLAB) Notes Payables (2011 - 2026)

Mesa Laboratories' (MLAB) quarterly Notes Payables came in at $77.2 million in Q2 2026, down 8.58% quarter-over-quarter from $84.5 million in Q1 2026.

Analysis

Mesa Laboratories (MLAB) Notes Payables (2011 - 2026) Analysis & Trends

Mesa Laboratories has disclosed Notes Payables across 2 years of filings, most recently posting $77.2 million for Q2 2026.

  • In Q2 2026, Notes Payables changed N/A year-over-year to $77.2 million; the TTM figure through Jun 2026 stood at $77.2 million (changed N/A YoY), while the FY2026 annual figure was $84.5 million, changed N/A from the prior year.
  • Notes Payables came in at $77.2 million for Q2 2026 at Mesa Laboratories, down from $84.5 million in the prior quarter.
  • In the past five years, Notes Payables ranged from a high of $84.5 million in Q1 2026 to a low of $77.2 million in Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Thermo Fisher Scientific 223.99 Bn 219.93 Bn 8.34 Bn
2 Danaher 141.56 Bn 137.22 Bn 3.61 Bn
3 Agilent Technologies 40.36 Bn 38.60 Bn 1.04 Bn
4 Illumina 30.41 Bn 29.24 Bn 770.00 Mn
5 Revvity 13.50 Bn 12.48 Bn 416.87 Mn
6 Bio-Techne 11.25 Bn 10.98 Bn 211.39 Mn
7 Bio-Rad Laboratories 9.88 Bn 8.26 Bn 345.80 Mn
8 Repligen 9.29 Bn 8.28 Bn 110.04 Mn
9 10x Genomics 8.62 Bn 8.06 Bn 112.50 Mn
10 Mesa Laboratories 684.72 Mn 652.49 Mn 39.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 77.25 Mn
Mar 31, 2026 84.50 Mn
Sep 30, 2011 1.00 Mn
Jun 30, 2011 1.00 Mn
Mar 31, 2011 600,000.00